Does Vitamin Supplementation Play a Role in Chronic Kidney Disease?

Overview

Journal Nutrients

Date 2023 Jul 14

PMID 37447174

Authors

Aleksandra Beata Juszczak

Maciej Kupczak

Tomasz Konecki

Affiliations

Soon will be listed here.

Abstract

Although the role of vitamins in the human body is proven, guidelines for patients with chronic kidney disease (CKD) remain unclear. This narrative review summarizes the findings of 98 studies of CKD and the effects of vitamin D, B, C, A, E, and K supplementation on patients on dialysis for CKD, with the aim of summarizing the existing guidelines. The findings are promising, showing the potential effectiveness of vitamin supplementation with, for example, vitamins B, D, or C. However, recommendations are still ambiguous, especially in the case of vitamins A and K, due to the potential toxicity associated with higher doses for patients. Continued research is needed to rigorously evaluate the effectiveness and carefully consider the potential risks of some vitamin supplementation for patients with CKD.

Citing Articles

Multivitamin supplementation and its impact in metabolic dysfunction-associated steatotic liver disease.

Ryu T, Chae S, Lee J, Han J, Yang H, Chung B Sci Rep. 2025; 15(1):8675.

PMID: 40082562 PMC: 11906897. DOI: 10.1038/s41598-025-92858-0.

Vitamin B12 deficiency in dialysis patients: risk factors, diagnosis, complications, and treatment: A comprehensive review.

Araji G, Keesari P, Chowdhry V, Valsechi-Diaz J, Afif S, Diab W World J Nephrol. 2024; 13(4):100268.

PMID: 39723360 PMC: 11572648. DOI: 10.5527/wjn.v13.i4.100268.

Vitamin A is associated with all-cause mortality in patients with chronic kidney disease: a population-based cohort study.

Feng Y, Li Y, Chen S, Hu N, Liao D Front Nutr. 2024; 11:1469844.

PMID: 39698241 PMC: 11652194. DOI: 10.3389/fnut.2024.1469844.

Utilization of complementary and alternative medicine by patients undergoing maintenance hemodialysis for chronic kidney disease in Taiwan: a descriptive investigation.

Tsai M, Chin C, Lee W, Huang Y, Cheng Y BMC Health Serv Res. 2024; 24(1):1412.

PMID: 39548442 PMC: 11568637. DOI: 10.1186/s12913-024-11912-1.

The Interplay between Liver and Adipose Tissue in the Onset of Liver Diseases: Exploring the Role of Vitamin Deficiency.

Tattoli I, Mathew A, Verrienti A, Pallotta L, Severi C, Andreola F Cells. 2024; 13(19.

PMID: 39404394 PMC: 11475612. DOI: 10.3390/cells13191631.

References

Thadhani R . Is calcitriol life-protective for patients with chronic kidney disease?. J Am Soc Nephrol. 2009; 20(11):2285-90. DOI: 10.1681/ASN.2009050494. View

Espe K, Raila J, Henze A, Krane V, Schweigert F, Hocher B . Impact of vitamin A on clinical outcomes in haemodialysis patients. Nephrol Dial Transplant. 2011; 26(12):4054-61. DOI: 10.1093/ndt/gfr171. View

Jamison R, Hartigan P, Kaufman J, Goldfarb D, Warren S, Guarino P . Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial. JAMA. 2007; 298(10):1163-70. DOI: 10.1001/jama.298.10.1163. View

Karamouzis I, Sarafidis P, Karamouzis M, Iliadis S, Haidich A, Sioulis A . Increase in oxidative stress but not in antioxidant capacity with advancing stages of chronic kidney disease. Am J Nephrol. 2007; 28(3):397-404. DOI: 10.1159/000112413. View

Jean G, Terrat J, Vanel T, Hurot J, Lorriaux C, Mayor B . Evidence for persistent vitamin D 1-alpha-hydroxylation in hemodialysis patients: evolution of serum 1,25-dihydroxycholecalciferol after 6 months of 25-hydroxycholecalciferol treatment. Nephron Clin Pract. 2008; 110(1):c58-65. DOI: 10.1159/000151534. View

Nanayakkara P, Kiefte-de Jong J, Ter Wee P, Stehouwer C, van Ittersum F, Olthof M . Randomized placebo-controlled trial assessing a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on plasma asymmetric dimethylarginine concentration in mild to moderate CKD. Am J Kidney Dis. 2008; 53(1):41-50. DOI: 10.1053/j.ajkd.2008.06.016. View

Fumeron C, Nguyen-Khoa T, Saltiel C, Kebede M, Buisson C, Drueke T . Effects of oral vitamin C supplementation on oxidative stress and inflammation status in haemodialysis patients. Nephrol Dial Transplant. 2005; 20(9):1874-9. DOI: 10.1093/ndt/gfh928. View

Pilz S, Iodice S, Zittermann A, Grant W, Gandini S . Vitamin D status and mortality risk in CKD: a meta-analysis of prospective studies. Am J Kidney Dis. 2011; 58(3):374-82. DOI: 10.1053/j.ajkd.2011.03.020. View

Manickavasagar B, McArdle A, Yadav P, Shaw V, Dixon M, Blomhoff R . Hypervitaminosis A is prevalent in children with CKD and contributes to hypercalcemia. Pediatr Nephrol. 2014; 30(2):317-25. PMC: 4282719. DOI: 10.1007/s00467-014-2916-2. View

10.

Coveney N, Polkinghorne K, Linehan L, Corradini A, Kerr P . Water-soluble vitamin levels in extended hours hemodialysis. Hemodial Int. 2010; 15(1):30-8. DOI: 10.1111/j.1542-4758.2010.00505.x. View

11.

Corken M, Porter J . Is vitamin B(6) deficiency an under-recognized risk in patients receiving haemodialysis? A systematic review: 2000-2010. Nephrology (Carlton). 2011; 16(7):619-25. DOI: 10.1111/j.1440-1797.2011.01479.x. View

12.

Tokmak F, Quack I, Schieren G, Sellin L, Rattensperger D, Holland-Letz T . High-dose cholecalciferol to correct vitamin D deficiency in haemodialysis patients. Nephrol Dial Transplant. 2008; 23(12):4016-20. DOI: 10.1093/ndt/gfn367. View

13.

Oksa A, Spustova V, Krivosikova Z, Gazdikova K, Fedelesova V, Lajdova I . Effects of long-term cholecalciferol supplementation on mineral metabolism and calciotropic hormones in chronic kidney disease. Kidney Blood Press Res. 2008; 31(5):322-9. DOI: 10.1159/000157177. View

14.

Kang H, Kim D, Lee S, Kim K, Han S, Kim K . Effects of low-dose niacin on dyslipidemia and serum phosphorus in patients with chronic kidney disease. Kidney Res Clin Pract. 2016; 32(1):21-6. PMC: 4716108. DOI: 10.1016/j.krcp.2012.12.001. View

15.

Kopple J, Mercurio K, Blumenkrantz M, Jones M, TALLOS J, Roberts C . Daily requirement for pyridoxine supplements in chronic renal failure. Kidney Int. 1981; 19(5):694-704. DOI: 10.1038/ki.1981.69. View

16.

Raimann J, Levin N, Craig R, Sirover W, Kotanko P, Handelman G . Is vitamin C intake too low in dialysis patients?. Semin Dial. 2012; 26(1):1-5. DOI: 10.1111/sdi.12030. View

17.

Elliott M, Booth S, Hopman W, Holden R . Assessment of potential biomarkers of subclinical vitamin K deficiency in patients with end-stage kidney disease. Can J Kidney Health Dis. 2015; 1:13. PMC: 4349792. DOI: 10.1186/2054-3581-1-13. View

18.

Holden R, Morton A, Garland J, Pavlov A, Day A, Booth S . Vitamins K and D status in stages 3-5 chronic kidney disease. Clin J Am Soc Nephrol. 2010; 5(4):590-7. PMC: 2849681. DOI: 10.2215/CJN.06420909. View

19.

Saab G, Young D, Gincherman Y, Giles K, Norwood K, Coyne D . Prevalence of vitamin D deficiency and the safety and effectiveness of monthly ergocalciferol in hemodialysis patients. Nephron Clin Pract. 2007; 105(3):c132-8. DOI: 10.1159/000098645. View

20.

Capelli I, Cianciolo G, Gasperoni L, Zappulo F, Tondolo F, Cappuccilli M . Folic Acid and Vitamin B12 Administration in CKD, Why Not?. Nutrients. 2019; 11(2). PMC: 6413093. DOI: 10.3390/nu11020383. View